Does NPLATE Cause Myelofibrosis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Myelofibrosis have been filed in association with NPLATE. This represents 2.6% of all adverse event reports for NPLATE.
7
Reports of Myelofibrosis with NPLATE
2.6%
of all NPLATE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Myelofibrosis From NPLATE?
Of the 7 reports, 1 (14.3%) resulted in death, 1 (14.3%) required hospitalization.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NPLATE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does NPLATE Cause?
Platelet count decreased (46)
Therapeutic response decreased (30)
Platelet count abnormal (28)
Death (26)
Haemorrhage (26)
Arthralgia (21)
Drug ineffective (19)
Purpura (19)
Hospitalisation (18)
Haemoglobin decreased (17)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)